Cargando…

Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19()

Detalles Bibliográficos
Autores principales:	Sánchez Cadena, Abraham David, Negreira Caamaño, Martín, Pérez Serrano, Raúl, Porras Leal, María Lourdes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062028/ https://www.ncbi.nlm.nih.gov/pubmed/36165388 http://dx.doi.org/10.1016/j.nefroe.2021.04.001

Ejemplares similares

Inmunoglobulinas por vía intravenosa: una alternativa terapéutica a tener en cuenta en el paciente trasplantado renal con COVID-19
por: Sánchez Cadena, Abraham David, et al.
Publicado: (2021)

Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
por: Loeffler, David A
Publicado: (2014)

Erratum: Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
por: Loeffler, David A
Publicado: (2015)

Desensitization in transplantation: is intravenous immunoglobulin the holy grail?
por: Palsson, Ragnar, et al.
Publicado: (2022)

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
por: Castle, Dan, et al.
Publicado: (2019)

Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study
por: Matignon, Marie, et al.
Publicado: (2017)

Clinical Efficacy of Intravenous Immunoglobulin for BK Polyomavirus-Associated Nephropathy After Living Kidney Transplantation
por: Matsumura, Soichi, et al.
Publicado: (2020)

Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia
por: Tatar, Erhan, et al.
Publicado: (2020)

Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis
por: Díez-Porras, Laura, et al.
Publicado: (2020)

Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury
por: Thom, Vivien, et al.
Publicado: (2017)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Atypical periodic alternating nystagmus responding to high-dose intravenous immunoglobulins: a case report
por: Argente-Escrig, Herminia, et al.
Publicado: (2017)

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients
por: Pilon, Caroline, et al.
Publicado: (2020)

Effectiveness of Intravenous Immunoglobulin Plus Plasmapheresis on Antibody-mediated Rejection or Thrombotic Microangiopathy in Iranian Kidney Transplant Recipient
por: Dashti-Khavidaki, Simin, et al.
Publicado: (2015)

Potential therapeutic approach of intravenous immunoglobulin against COVID-19
por: Kolahchi, Zahra, et al.
Publicado: (2021)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Intravenous Immunoglobulin for Hypogammaglobulinemia after Lung Transplantation: A Randomized Crossover Trial
por: Lederer, David J., et al.
Publicado: (2014)

Rejection-triggered haemophagocytic syndrome in renal transplantation successfully treated with intravenous immunoglobulin
por: Marques, Igor Denizarde Bacelar, et al.
Publicado: (2013)

Considering the Closure of Arteriovenous Fistulas in Kidney Transplant Recipients
por: Xiao, Zhuotao, et al.
Publicado: (2023)

Intravenous immunoglobulin for acute hemorrhagic leukoencephalitis refractory to plasmapheresis
por: Panchal, Apurva, et al.
Publicado: (2018)

Adaptive and Innate Immune Responses in Autism: Rationale for Therapeutic Use of Intravenous Immunoglobulin
por: Gupta, Sudhir, et al.
Publicado: (2010)

Impacto de la pandemia COVID-19 sobre los ingresos hospitalarios en cardiología
por: Negreira Caamaño, Martín, et al.
Publicado: (2020)

Impact of COVID-19 pandemic in cardiology admissions()
por: Negreira Caamaño, Martín, et al.
Publicado: (2020)

Disfunción sinusal florida en un paciente con miocardiopatía amiloide
por: Negreira-Caamaño, Martín, et al.
Publicado: (2023)

Intravenous immunoglobulin therapy for refractory Clostridium difficile toxin colitis in chronic kidney disease: case reports and literature review
por: Chandrasekar, T, et al.
Publicado: (2008)

Exquisite response to intravenous immunoglobulin in Susac syndrome during pregnancy
por: Gomez-Figueroa, Enrique, et al.
Publicado: (2017)

Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review
por: Choi, Eun Woo, et al.
Publicado: (2021)

Intravenous Immunoglobulin in the Management of Lupus Nephritis
por: Wenderfer, Scott E., et al.
Publicado: (2012)

Pemphigoid gestationis and intravenous immunoglobulin therapy()
por: Yang, Anes, et al.
Publicado: (2018)

Intravenous Immunoglobulin for Overwhelming Postsplenectomy Infection
por: Nakamura, Kensuke, et al.
Publicado: (2021)

Intravenous Immunoglobulin: Revisited – My Experience
por: Vaishampayan, Sanjeev S., et al.
Publicado: (2021)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab
por: Vasconcelos, Joana, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder
por: Rossignol, Daniel A, et al.
Publicado: (2021)

Severe Periodontal Disease Associated with Long-Term Treatment with Intravenous Immunoglobulin
por: Corrêa, Jôice Dias, et al.
Publicado: (2014)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin
por: Ban, Tae Hyun, et al.
Publicado: (2021)

Intravenous Immunoglobulin Treatment in Multifocal Motor Neuropathy
por: van der Pol, W.-Ludo, et al.
Publicado: (2010)

Prioritization of Evidence-Based Indications for Intravenous Immunoglobulin
por: Orange, Jordan S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rh28uvo0dnsin7ncg66nl5cuk2